S. Intidhar Labidi-Galy results 1
· Newest (Page 1/1, per page 25)
Author: S. Intidhar Labidi-Galy ×Clear All Filters
Search Results
BRCA1 and BRCA2 play a central role in DNA repair and their germline pathogenic variants (g BRCA ) confer a high risk for developing breast and ovarian cancer. Standard chemotherapy regimens for these cancers include DNA-damaging agents. We hypothesized that gBRCA carriers might be at higher risk of developing chemotherapy-related hematologic toxicity and therapy-related myeloid neoplasms (t-MN). We conducted a retrospective s...
Previous1Next